Skip to main content

Treatment with stem cells, a new era in medical science.......














A new Era is coming forward in the treatment of human body. That is the STEM CELL THERAPY. If this treatment comes forward then medical science can treat many of those major diseases that are killing a large number of people each year. There are many diseases now that can't be cured by medical treatment, like Paralysis. If a patient has paralysis then doctors give him only some supportive treatment to improve his nerve supply on that affected area. But it can't give a redical cure. Because if a nerve cell damaged it cant be regenerated due to it is mane if stable cells. But, if a stem cell is replaced on that area then it can regenerate a nerve cell because stem cell can grow in the form of any cells or tissues, it has that capacity. Although a stem cell can grow in any form of a tissue or an organ. So, if we can place a stem cell in that affected hand or leg then this stem cell will grow under control and can regenerate into that original tissue. So, the patient will be cured ultimately.
And this theory made our scientists happy. And from this theory many researches are going on under laboratory. We all hope that finally we will get a new Era on medical treatment.

Comments

Popular posts from this blog

Artificial pancreas ... an option

Coming Soon: 'Artificial Pancreas' Options for Diabetes Miriam E Tucker June 20, 2016   NEW ORLEANS — Nearly closed-loop systems (also referred to as an "artificial pancreas") for improving glycemic control and minimizing hypoglycemia in type 1 diabetes are advancing rapidly, including iterations that deliver insulin alone, insulin with glucagon, or glucagon alone. Findings for several of the products in development demonstrating improvements in glycemic control and reductions in hypoglycemia were presented here at the  American Diabetes Association (ADA) 2016 Scientific Sessions . "Some people may do well on insulin only, while others may need glucagon," Vincent Crabtree, PhD, director of the artificial pancreas program at JDRF, in New York, told  Medscape Medical News , adding, "JDRF would like people to have choice, and we'd like all to be covered [by payers]." The insulin-only hybrid closed-loop 670G system (Medtronic MiniMed) is the...

Do you know that ??

Dear Readers, do you know about risk factors of Lung cancer ? If you are residing in a city where polution is a great problem, like air pollution, then you be attacked by lung cancer. Also if you are a regular smoker then you are in great risk. Researches shows that only inhaling toxic smokes are not important. If you are containing " Genes " that causes lung cancer then you are in great risks. So, it is proved clinicaly that if you dont have a lung cancer gene then you may not attacked by lung cancer though you are a smoker or anything like this. But, the problem is we dont know that whether we have the gene responsible for lung cancer or not. So, it will better to quit smoking if you are a smoker. Also, clinicaly doctors get those poatients who have alredy developed a cancer after exposing to the risk factors for several years. So, if a person quits smoking even after 15years he will get rid from lung cancer. But, he must in a great risk.

CellSight Contributes Light-Sensitive Retinal Organoids and RPE Cells to New AMD Study

  Department of Ophthalmology Written by  Kara Mason  | December 06, 2023 A partnership between ophthalmology researchers at the  University of Colorado School of Medicine  and Johns Hopkins University expands the understanding of how oxidative stress contributes to the development of choroidal neovascularization (CNV) in patients with age-related macular degeneration (AMD). To study the roles oxidative stress, a condition in which the body lacks antioxidants, and hypoxia play in the progression of AMD, Johns Hopkins University researchers turned to  CellSight , the ocular stem cell and regeneration research program in the  CU Department of Ophthalmology,  for tools that allow researchers to explore specific conditions relevant to AMD. Using human-induced pluripotent stem cells, a type of stem cells that are generated or induced-from cells obtained from an adult person's skin or blood,  CellSight  investigators can recreate human retinal...